Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Osteoporosis | Research

H. pylori infection and osteoporosis: a large-scale observational and mendelian randomization study

Authors: Ling Zhang, Daya Zhang, Ling Wei, Yan Zhou, Ximei Li, Runxiang Chen, Xiaodong Zhang, Shiju Chen, Feihu Bai

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Purpose

There is controversy concerning the relationship between Helicobacter pylori (H. pylori) infection and osteoporosis. This study is to examine the causal relationship between H. pylori infection and osteoporosis and to analyze the potential mechanism underlying the relationship.

Methods

The clinical data of H. pylori infection and bone mineral density from patients or physical examiner with good general condition in our hospital between September 2019 and September 2020 were retrospectively collected. The relationship between H. pylori infection and osteoporosis was compared and analyzed, using logistic regression to examine the potential mechanism underlying the association. To investigate the causal effects of H. pylori infection and osteoporosis, we conducted a two-sample bidirectional Mendelian randomization (MR) analysis.

Results

A total of 470 patients were positive for H. pylori, with a detection rate of 52.22%. It was found that age, SBP, FPG, DBP, ALB, LDL-C, hs-CRP, and OC were positively correlated with osteoporosis, while negative correlations were observed with BMI, LYM, ALB, TP, TG, HDL-C, SCr, UA, and VitD. After stratified analysis of sex and age, it was found that there was a significant correlation between H. pylori infection and osteoporosis. The levels of SBP, ALP, FPG, LDL-C, hs-CRP, and OC in both H. pylori-positive group and osteoporosis group were higher than those in the H. pylori-negative group while the levels of BMI, ALB, TP, HDL-C, SCr, UA, and VitD in the positive group were significantly lower than those in the negative group. Logistic regression analyses with gender and age showed that ALB, FPG, HDL-C, and VitD were common risk factors for osteoporosis and H. pylori infection. In the MR analysis, the IVW results found a positive effect of H. pylori infection on osteoporosis (OR = 1.0017, 95% CI: 1.0002–1.0033, P = 0.0217). Regarding the reverse direction analysis, there was insufficient evidence to prove the causal effects of osteoporosis on H. pylori infection.

Conclusion

Our study provides evidence for causal effects of H. pylori infection on osteoporosis. H. pylori may affect osteoporosis through serum albumin, high-density lipoprotein, fasting blood glucose and vitamin D.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zhang Yanjun L, Yiting YX. Analysis of Helicobacter pylori infection and related factors in healthy population. J Clinicalmilitary Med. 2015;43(11):809–12. Zhang Yanjun L, Yiting YX. Analysis of Helicobacter pylori infection and related factors in healthy population. J Clinicalmilitary Med. 2015;43(11):809–12.
2.
go back to reference Tursi A, Cammarota G, Papa A, Cuoco L, Gentiloni N, Fedeli P, et al. The modes of transmission of Helicobacter pylori infection. Recenti Prog Med. 1997;88(5):232–6.PubMed Tursi A, Cammarota G, Papa A, Cuoco L, Gentiloni N, Fedeli P, et al. The modes of transmission of Helicobacter pylori infection. Recenti Prog Med. 1997;88(5):232–6.PubMed
3.
go back to reference Miftahussurur M, Yamaoka Y, Graham DY. Helicobacter pylori as an oncogenic pathogen, revisited. Expert Rev Mol Med. 2017;21:19:e4.CrossRef Miftahussurur M, Yamaoka Y, Graham DY. Helicobacter pylori as an oncogenic pathogen, revisited. Expert Rev Mol Med. 2017;21:19:e4.CrossRef
4.
go back to reference Krajden S, Fuksa M, Anderson J, Kempston J, Boccia A, Petrea C, et al. Examination of human stomach biopsies, saliva, and dental plaque for Campylobacter pylori. J Clin Microbiol. 1989;27(6):1397–8.CrossRefPubMedPubMedCentral Krajden S, Fuksa M, Anderson J, Kempston J, Boccia A, Petrea C, et al. Examination of human stomach biopsies, saliva, and dental plaque for Campylobacter pylori. J Clin Microbiol. 1989;27(6):1397–8.CrossRefPubMedPubMedCentral
5.
go back to reference Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325(16):1127–31.CrossRefPubMed Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325(16):1127–31.CrossRefPubMed
6.
go back to reference Chen LW, Chen FP, Hsieh CW, Kuo SF, Chien RN. Analysis of the associations among Helicobacter pylori infection, adiponectin, leptin, and 10-year fracture risk using the fracture risk assessment tool: a cross-sectional community-based study. PLoS ONE. 2017;12(4):e0175365.CrossRefPubMedPubMedCentral Chen LW, Chen FP, Hsieh CW, Kuo SF, Chien RN. Analysis of the associations among Helicobacter pylori infection, adiponectin, leptin, and 10-year fracture risk using the fracture risk assessment tool: a cross-sectional community-based study. PLoS ONE. 2017;12(4):e0175365.CrossRefPubMedPubMedCentral
7.
go back to reference Xu ZH, Zhang J, Yang D, Zhang JH. Progress of research between Helicobacter pylori infection and osteoporosis. Zhongguo Gu Shang. 2011;24(11):966–8.PubMed Xu ZH, Zhang J, Yang D, Zhang JH. Progress of research between Helicobacter pylori infection and osteoporosis. Zhongguo Gu Shang. 2011;24(11):966–8.PubMed
8.
go back to reference Ferrari SL, Karasik D, Liu J, Karamohamed S, Herbert AG, Cupples LA, et al. Interactions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women from the Framingham osteoporosis study. J Bone Min Res. 2004;19(4):552–9.CrossRef Ferrari SL, Karasik D, Liu J, Karamohamed S, Herbert AG, Cupples LA, et al. Interactions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women from the Framingham osteoporosis study. J Bone Min Res. 2004;19(4):552–9.CrossRef
9.
go back to reference Kakehasi AM, Rodrigues CB, Carvalho AV, Barbosa AJ. Chronic gastritis and bone mineral density in women. Dig Dis Sci. 2009;54(4):819–24.CrossRefPubMed Kakehasi AM, Rodrigues CB, Carvalho AV, Barbosa AJ. Chronic gastritis and bone mineral density in women. Dig Dis Sci. 2009;54(4):819–24.CrossRefPubMed
14.
go back to reference Xia Weibo Z, Zhenlin L, Hua J, Xiaolan Y, Wei F, Qin. Guidelines for diagnosis and treatment of primary osteoporosis (2017). Chin J Osteoporos. 2019;25(03):281–309. Xia Weibo Z, Zhenlin L, Hua J, Xiaolan Y, Wei F, Qin. Guidelines for diagnosis and treatment of primary osteoporosis (2017). Chin J Osteoporos. 2019;25(03):281–309.
15.
go back to reference Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658–65.CrossRefPubMedPubMedCentral Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658–65.CrossRefPubMedPubMedCentral
16.
go back to reference Zheng Yansong C, Zhilai S, Xiaoyong W. Cross-sectional analysis of gastric Helicobacter pylori infection in physical examination population. Chin J Clin (Electronic Edition). 2013;7(22):10044–7. Zheng Yansong C, Zhilai S, Xiaoyong W. Cross-sectional analysis of gastric Helicobacter pylori infection in physical examination population. Chin J Clin (Electronic Edition). 2013;7(22):10044–7.
17.
go back to reference Wroblewski LE, Peek RM Jr, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010;23(4):713–39.CrossRefPubMedPubMedCentral Wroblewski LE, Peek RM Jr, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010;23(4):713–39.CrossRefPubMedPubMedCentral
18.
go back to reference Sardone LD, Renlund R, Willett TL, Fantus IG, Grynpas MD. Effect of rosiglitazone on bone quality in a rat model of insulin resistance and osteoporosis.Diabetes. 2011;60(12):3271–8. Sardone LD, Renlund R, Willett TL, Fantus IG, Grynpas MD. Effect of rosiglitazone on bone quality in a rat model of insulin resistance and osteoporosis.Diabetes. 2011;60(12):3271–8.
19.
go back to reference Guo, Ying. Pei Dongmei. Study on the relationship between Helicobacter pylori infection and bone in men. J Practical Clin Med. 2019;23(09):34–7. Guo, Ying. Pei Dongmei. Study on the relationship between Helicobacter pylori infection and bone in men. J Practical Clin Med. 2019;23(09):34–7.
20.
go back to reference Kim TJ, Lee H, Min YW, Min BH, Lee JH, Rhee PL, et al. Cohort study of Helicobacter pylori infection and the risk of incident osteoporosis in women. J Gastroenterol Hepatol. 2021;36(3):657–63.CrossRefPubMed Kim TJ, Lee H, Min YW, Min BH, Lee JH, Rhee PL, et al. Cohort study of Helicobacter pylori infection and the risk of incident osteoporosis in women. J Gastroenterol Hepatol. 2021;36(3):657–63.CrossRefPubMed
21.
go back to reference Wang T, Li X, Zhang Q, Ge B, Zhang J, Yu L, et al. Relationship between Helicobacter pylori infection and osteoporosis: a systematic review and meta-analysis. BMJ Open. 2019;9(6):e027356.CrossRefPubMedPubMedCentral Wang T, Li X, Zhang Q, Ge B, Zhang J, Yu L, et al. Relationship between Helicobacter pylori infection and osteoporosis: a systematic review and meta-analysis. BMJ Open. 2019;9(6):e027356.CrossRefPubMedPubMedCentral
22.
go back to reference Upala S, Sanguankeo A, Wijarnpreecha K, Jaruvongvanich V. Association between Helicobacter pylori infection and osteoporosis: a systematic review and meta-analysis. J Bone Min Metab. 2016;34(4):482–3.CrossRef Upala S, Sanguankeo A, Wijarnpreecha K, Jaruvongvanich V. Association between Helicobacter pylori infection and osteoporosis: a systematic review and meta-analysis. J Bone Min Metab. 2016;34(4):482–3.CrossRef
23.
go back to reference Papamichael KX, Papaioannou G, Karga H, Roussos A, Mantzaris GJ. Helicobacter pylori infection and endocrine disorders: is there a link?World. J Gastroenterol. 2009;15(22):2701–7. Papamichael KX, Papaioannou G, Karga H, Roussos A, Mantzaris GJ. Helicobacter pylori infection and endocrine disorders: is there a link?World. J Gastroenterol. 2009;15(22):2701–7.
24.
go back to reference Asaoka D, Nagahara A, Hojo M, Sasaki H, Shimada Y, Yoshizawa T, Osada T, Watanabe S. The relationship between H. pylori infection and osteoporosis in Japan. Gastroenterol Res Pract. 2014;2014:340765.CrossRefPubMedPubMedCentral Asaoka D, Nagahara A, Hojo M, Sasaki H, Shimada Y, Yoshizawa T, Osada T, Watanabe S. The relationship between H. pylori infection and osteoporosis in Japan. Gastroenterol Res Pract. 2014;2014:340765.CrossRefPubMedPubMedCentral
25.
go back to reference Ravindra A, Igweonu-Nwakile C, Ali EO, Paul S, Yakkali S, Balani S. Establishing the Association between Osteoporosis and peptic Ulcer Disease: a systematic review. Cureus. 2022;14(7):e27188.PubMedPubMedCentral Ravindra A, Igweonu-Nwakile C, Ali EO, Paul S, Yakkali S, Balani S. Establishing the Association between Osteoporosis and peptic Ulcer Disease: a systematic review. Cureus. 2022;14(7):e27188.PubMedPubMedCentral
26.
go back to reference Xu Y, Xiaozhi L. Analysis of the relationship between gastrointestinal symptoms and Helicobacter pylori infection in healthy subjects. J Qiqihar Med Coll. 2009;30(14):1697. Xu Y, Xiaozhi L. Analysis of the relationship between gastrointestinal symptoms and Helicobacter pylori infection in healthy subjects. J Qiqihar Med Coll. 2009;30(14):1697.
27.
go back to reference Liu J, Wang Y, Zhao Q, Luo R, Xiao M, Zhang M, et al. Prevalence and risk factors for Helicobacter pylori infection in southwest China: a study of health examination participants based on 13 C-urea breath test. Turk J Med Sci. 2017;47(5):1456–62.CrossRefPubMed Liu J, Wang Y, Zhao Q, Luo R, Xiao M, Zhang M, et al. Prevalence and risk factors for Helicobacter pylori infection in southwest China: a study of health examination participants based on 13 C-urea breath test. Turk J Med Sci. 2017;47(5):1456–62.CrossRefPubMed
28.
go back to reference New SA, Millward DJ. Calcium, protein, and fruit and vegetables as dietary determinants of bone health. Am J Clin Nutr. 2003;77(5):1340–1.CrossRefPubMed New SA, Millward DJ. Calcium, protein, and fruit and vegetables as dietary determinants of bone health. Am J Clin Nutr. 2003;77(5):1340–1.CrossRefPubMed
29.
go back to reference Orwoll ES. The effects of dietary protein insufficiency and excess on skeletal health. Bone. 1992;13(4):343–50.CrossRefPubMed Orwoll ES. The effects of dietary protein insufficiency and excess on skeletal health. Bone. 1992;13(4):343–50.CrossRefPubMed
30.
go back to reference Lunde AV, Barrett-Connor E, Morton DJ. Serum albumin and bone mineral density in healthy older men and women: the Rancho Bernardo Study. Osteoporos Int. 1998;8(6):547–51.CrossRefPubMed Lunde AV, Barrett-Connor E, Morton DJ. Serum albumin and bone mineral density in healthy older men and women: the Rancho Bernardo Study. Osteoporos Int. 1998;8(6):547–51.CrossRefPubMed
31.
go back to reference Li Z. Relationship between serum albumin, haemoglobin and osteoporosis[D]. Fujian Medical University [2024-02-26].DOI:CNKI:CDMD:2.1016.748077. Li Z. Relationship between serum albumin, haemoglobin and osteoporosis[D]. Fujian Medical University [2024-02-26].DOI:CNKI:CDMD:2.1016.748077.
32.
go back to reference Shujuan F. Qingxiang Dai.Research Progress on the correlation mechanism between obesity and Osteoporosis.Advances in Clinical Medicine, 2022, 12(7), 6469–74. Shujuan F. Qingxiang Dai.Research Progress on the correlation mechanism between obesity and Osteoporosis.Advances in Clinical Medicine, 2022, 12(7), 6469–74.
33.
go back to reference Zhu Chunying Z, Yingfu, Li Zhihong. Correlation between Helicobacter pylori infection and diabetes mellitus. Hebei Med. 2017;39(03):445–7. Zhu Chunying Z, Yingfu, Li Zhihong. Correlation between Helicobacter pylori infection and diabetes mellitus. Hebei Med. 2017;39(03):445–7.
34.
go back to reference Han X, Li Y, Wang J, Liu B, Hu H, Li X, et al. Helicobacter pylori infection is associated with type 2 diabetes among a middle- and old-age Chinese population. Diabetes Metab Res Rev. 2016;32(1):95–101.CrossRefPubMed Han X, Li Y, Wang J, Liu B, Hu H, Li X, et al. Helicobacter pylori infection is associated with type 2 diabetes among a middle- and old-age Chinese population. Diabetes Metab Res Rev. 2016;32(1):95–101.CrossRefPubMed
35.
36.
go back to reference Raisingani M, Preneet B, Kohn B, Yakar S. Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH/IGF-1 axis. Growth Horm IGF Res. 2017;34:13–21.CrossRefPubMedPubMedCentral Raisingani M, Preneet B, Kohn B, Yakar S. Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH/IGF-1 axis. Growth Horm IGF Res. 2017;34:13–21.CrossRefPubMedPubMedCentral
37.
go back to reference KimTY SAL. Diabetes and bone marrow adiposity. Curr Osteoporos Rep. 2016;14(6):337–44.CrossRef KimTY SAL. Diabetes and bone marrow adiposity. Curr Osteoporos Rep. 2016;14(6):337–44.CrossRef
38.
go back to reference Zhao P, Zhang C. Research Progress on correlation between diabetes Mellitus and Osteoporosis.Advances in Clinical Medicine, 2022, 12(5), 4858–63. Zhao P, Zhang C. Research Progress on correlation between diabetes Mellitus and Osteoporosis.Advances in Clinical Medicine, 2022, 12(5), 4858–63.
39.
go back to reference Abdel-Razik A, Mousa N, Shabana W, Refaey M, Elhelaly R, Elzehery R, et al. Helicobacter pylori and non-alcoholic fatty liver disease: a new enigma? Helicobacter. 2018;23(6):e12537.CrossRefPubMed Abdel-Razik A, Mousa N, Shabana W, Refaey M, Elhelaly R, Elzehery R, et al. Helicobacter pylori and non-alcoholic fatty liver disease: a new enigma? Helicobacter. 2018;23(6):e12537.CrossRefPubMed
40.
go back to reference Adachi K, Mishiro T, Okimoto E, Kinoshita Y. Influence of the degree of gastric mucosal atrophy on the serum lipid levels before and after the eradication of Helicobacter pylori infection. Intern Med. 2018;57(21):3067–73.CrossRefPubMedPubMedCentral Adachi K, Mishiro T, Okimoto E, Kinoshita Y. Influence of the degree of gastric mucosal atrophy on the serum lipid levels before and after the eradication of Helicobacter pylori infection. Intern Med. 2018;57(21):3067–73.CrossRefPubMedPubMedCentral
41.
go back to reference Yamaguchi T, Sugimoto T, Yano S, Yamauchi M, Sowa H, Chen Q. Plasma lipids and osteoporosis in postmenopausal women. Endocr J. 2002;49(2):211–7.CrossRefPubMed Yamaguchi T, Sugimoto T, Yano S, Yamauchi M, Sowa H, Chen Q. Plasma lipids and osteoporosis in postmenopausal women. Endocr J. 2002;49(2):211–7.CrossRefPubMed
42.
go back to reference Samelson EJ, Cupples LA, Hannan MT, Wilson PW, Williams SA, Vaccarino V, et al. Long-term effects of serum cholesterol on bone mineral density in women and men: the Framingham osteoporosis study. Bone. 2004;34(3):557–61.CrossRefPubMed Samelson EJ, Cupples LA, Hannan MT, Wilson PW, Williams SA, Vaccarino V, et al. Long-term effects of serum cholesterol on bone mineral density in women and men: the Framingham osteoporosis study. Bone. 2004;34(3):557–61.CrossRefPubMed
43.
go back to reference Han H, Li R, Fu D, Zhou H, Zhan Z, Wu Y, Meng B. Correlation between bone density, bone metabolism markers with lipid metabolism markers and body mass index. BMC Musculoskelet Disord. 2024;25(1):162.CrossRefPubMedPubMedCentral Han H, Li R, Fu D, Zhou H, Zhan Z, Wu Y, Meng B. Correlation between bone density, bone metabolism markers with lipid metabolism markers and body mass index. BMC Musculoskelet Disord. 2024;25(1):162.CrossRefPubMedPubMedCentral
44.
go back to reference Anderson PH, Atkins GJ. The skeleton as an intracrine organ for vitamin D metabolism. Mol Aspects Med. 2008;29(6):397–406.CrossRefPubMed Anderson PH, Atkins GJ. The skeleton as an intracrine organ for vitamin D metabolism. Mol Aspects Med. 2008;29(6):397–406.CrossRefPubMed
45.
go back to reference Cranney A, Horsley T, O’Donnell S, Weiler H, Puil L, Ooi D, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep). 2007;158:1–235. Cranney A, Horsley T, O’Donnell S, Weiler H, Puil L, Ooi D, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep). 2007;158:1–235.
46.
go back to reference Antico A, Tozzoli R, Giavarina D, Tonutti E, Bizzaro N. Hypovitaminosis D as predisposing factor for atrophic type a gastritis: a case-control study and review of the literature on the interaction of vitamin D with the immune system. Clin Rev Allergy Immunol. 2012;42(3):355–64.CrossRefPubMed Antico A, Tozzoli R, Giavarina D, Tonutti E, Bizzaro N. Hypovitaminosis D as predisposing factor for atrophic type a gastritis: a case-control study and review of the literature on the interaction of vitamin D with the immune system. Clin Rev Allergy Immunol. 2012;42(3):355–64.CrossRefPubMed
Metadata
Title
H. pylori infection and osteoporosis: a large-scale observational and mendelian randomization study
Authors
Ling Zhang
Daya Zhang
Ling Wei
Yan Zhou
Ximei Li
Runxiang Chen
Xiaodong Zhang
Shiju Chen
Feihu Bai
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09196-1

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.